Acute Sedentary Behaviour and Markers of Cardiometabolic Risk: A Systematic Review of Intervention Studies

Table 1

Characteristics of included studies.

Reference	Design	First author	Year	Country	𝑛 (M/F)	Age range	Mean age	Modality	Duration	Outcomes	Downs and Black
[37]	RCT	Yaroshenko	1998	Greece	30 (30/0)	22–26	24.8	BR	7 days	TG	24
[33]	RCT	Zorbas	1999	Bulgaria	30 (30/0)	22–26	24.3	BR	7 days	FG	24
[22]	RCO	Duran-Valdez	2008	USA	10 (2/8)	24–72	46.2	BR	2 days	FI, FG, IS	21
[11]	RCO	Stephens	2010	USA	12 (6/6)	19–32	26.1	SIT	1 day	FI, FG, IS	24
[39]	RCO	Dunstan	2012	Australia	19 (11/8)	45–65	53.8	SIT	5 hours	IS, GT	27
[42]	RCO	Nygaard	2009	Norway	13 (0/13)	>50		SIT	2 hours	GT	23
[21]	NT	Alibegovic	2010	Denmark	38 (38/0)		25.0	BR	7 days	FI	23
[31]	NT	Alibegovic	2009	Denmark	33 (33/0)		25.6	BR	7 days	FI	23
[23, 47]	NT	Blanc	2000	France	16 (8/8)		30.2	HDBR	6 days	FI, FG, IS, GT	23
[35]	NT	Dolkas	1977	USA	7 (7/0)	19–22	20.0	BR	4 days	FG	21
[25]	NT	Barbe	1999	France	8 (8/0)	23–31	27.1	HDBR	5 days	FI, FG	21
[10]	NT	Hamburg	2007	USA	20 (14/6)		30.7	BR	5 days	FI, FG, IS, TG	23
[20]	NT	Katkov	1979	Russia	5 (5/0)		34.0	BR	5 days	FG	17
[41]	NT	Kiilerich	2011	Denmark	6 (6/0)	22–36	28.7	BR	7 days	IS, GT
[36]	NT	Ksinantova	2002	Slovakia	15 (15/0)		34.0	HDBR	4 days	FG	20
[29]	NT	Lipman	1972	USA	7 (7/0)	18–20		BR	3 days	FI, IS, GT	18
[32]	NT	Kanikowska	2010	Japan	8 (8/0)		27.0	HDBR	5 days	FI, FG, IS
[27, 40]	NT	Mikines	1989	Denmark	6 (6/0)		25.0	BR	7 days	FI, FG, IS, GT	20
[30]	NT	Moro	2007	France	8 (8/0)	22–27	23.0	HDBR, SIT	4 hours	FI, FG	20
[34]	NT	Navasiolava	2010	Russia	8 (8/0)		23.0	BR	7 days	FG, TG, HDL, LDL	22
[26]	NT	Nygren	1997	Sweden	6 (6/0)		24.1	BR	1 day	FI, FG, IS	22
[19]	NT	Richter	1989	Denmark	5 (5/0)	22–24		CAST	7 days	IS	20
[24, 48, 49]	NT	Smorawinski	1996	Poland	29 (29/0)		20.10	BR	3 days	IS, GT	19
[28]	NT	Stuart	1988	USA	6 (6/0)	21–28	23.0	BR	7 days	FI, FG, IS, GT	22
[38]	NT	Yanagibori	1997	Japan	23 (13/10)	19–25		BR	3 days	IS, GT, TG, HDL, LDL	22

RCT: randomized controlled trial; RCO: randomized crossover; NT: nonrandomized trial; M: male; F: female; HDBR: head-down bed rest; 22BR: horizontal or head-up bed rest; SIT: sitting; CAST: casting; FG: fasting glucose; FI: fasting insulin; TG: triglycerides; HDL: HDL-cholesterol; LDL: LDL-cholesterol; IS: insulin sensitivity; GT: glucose tolerance.
When an intervention was described in more than one paper, the author name and year are taken from the earliest publication.